Nicorette Lozenge

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:tobacco
gptkbp:available_in multiple flavors
gptkbp:available_in_strengths 2 mg and 4 mg
gptkbp:available_over_the_counter gptkb:true
gptkbp:brand gptkb:Nicorette
gptkbp:can_be_used_for reducing withdrawal symptoms
gptkbp:can_be_used_with other cessation methods
gptkbp:can_cause gptkb:addiction
gptkbp:care_instructions dissolve in mouth
gptkbp:clinical_trial conducted for efficacy
gptkbp:contains flavoring agents
sweeteners
coloring agents
gptkbp:contraindication pregnancy
heart disease
gptkbp:dosage_form 2 mg
4 mg
1 lozenge every 1-2 hours
gptkbp:duration varies by individual
up to 12 weeks
gptkbp:first_introduced 1990s
gptkbp:flavor gptkb:cinnamon
gptkb:Loewe
gptkb:fruit
gptkb:mint
gptkbp:form gptkb:Loewe
https://www.w3.org/2000/01/rdf-schema#label Nicorette Lozenge
gptkbp:ingredients nicotine
gptkbp:interacts_with certain medications
gptkbp:is_considered a safe alternative to smoking
gptkbp:is_part_of Nicotine replacement therapy regimen
gptkbp:is_recommended_by gptkb:healthcare_professionals
gptkbp:is_recommended_for as needed for cravings
gptkbp:is_used_in gptkb:children
gptkbp:manufacturer gptkb:Johnson_&_Johnson
gptkbp:marketed_as smoking aid
gptkbp:packaging blister pack
gptkbp:part_of Nicotine replacement therapy products
gptkbp:provides_guidance_on included in smoking cessation guidelines
gptkbp:regulatory_compliance FDA approved
gptkbp:release_region multiple countries
gptkbp:research support effectiveness
gptkbp:side_effect nausea
cough
throat irritation
mouth sores
gptkbp:storage store at room temperature
gptkbp:success_rate increases with counseling
gptkbp:sugar_content gptkb:true
gptkbp:suitable_for non-smokers
gptkbp:symptoms may help alleviate
gptkbp:target_audience smokers
gptkbp:used_for smoking cessation
gptkbp:user_feedback generally positive
gptkbp:bfsParent gptkb:GSK_Consumer_Healthcare
gptkbp:bfsLayer 6